Kombinovaná chemoterapie s blinatumomabem nebo bez něj v léčbě pacientů s nově diagnostikovanou akutní lymfoblastickou leukémií BCR-ABL-negativní linie B
Randomizovaná studie fáze III s Blinatumomabem pro nově diagnostikovanou akutní lymfoblastickou leukémii BCR-ABL negativní linie B u dospělých
This randomized phase III trial studies combination chemotherapy with blinatumomab to see how well it works compared to induction chemotherapy alone in treating patients with newly diagnosed breakpoint cluster region (BCR)-c-abl oncogene 1, non-receptor tyrosine kinase (ABL)-negative B lineage acute lymphoblastic leukemia. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as blinatumomab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. It is not yet known whether combination chemotherapy is more effective with or without blinatumomab in treating newly diagnosed acute lymphoblastic leukemia.
Přehled studie
Postavení
Postavení
Podmínky
Podmínky
Intervence / Léčba
Intervence / Léčba
- Lék: Cyclophosphamide
- Lék: Prednisone
- Postup: Bone Marrow Biopsy
- Postup: Biospecimen Collection
- Biologický: Rituximab
- Lék: Vincristine
- Lék: Vincristine Sulfate
- Lék: Dexamethasone
- Postup: Allogeneic Hematopoietic Stem Cell Transplantation
- Biologický: Blinatumomab
- Postup: Bone Marrow Aspiration
- Lék: Cytarabine
- Lék: Daunorubicin
- Lék: Daunorubicin Hydrochloride
- Lék: Etoposide
- Lék: Leucovorin Calcium
- Postup: Lumbar Puncture
- Lék: Mercaptopurine
- Lék: Methotrexate
- Lék: Pegaspargase
- Postup: X-Ray Imaging
Detailní popis
PRIMARY OBJECTIVE:
I. To compare the overall survival (OS) of blinatumomab in conjunction with chemotherapy to chemotherapy alone in patients with BCR-ABL-negative B cell precursor acute lymphoblastic leukemia (ALL) who are minimal residual disease (MRD) negative after induction and intensification chemotherapy, based on multiparameter flow cytometric (MFC) assessment of residual blasts.
SECONDARY OBJECTIVES:
I. To compare the relapse-free survival (RFS) of blinatumomab in conjunction with chemotherapy to chemotherapy alone in MRD negative patients after induction and intensification chemotherapy.
II. To compare the OS and RFS of those patients who are MRD positive (+) at step 3 randomization/registration and then convert to MRD negative (-) after 2 cycles of blinatumomab to those patients who are MRD- at randomization and remain MRD- after 2 cycles of blinatumomab or consolidation chemotherapy.
III. To assess the toxicities of blinatumomab in this patient population. IV. To assess the toxicities of the modified E2993 chemotherapy regimen in this patient population.
V. To describe the outcome of patients who proceed to allogeneic blood or marrow transplant after treatment with or without blinatumomab.
LABORATORY OBJECTIVES:
I. To determine differences in MRD kinetics among patients with the BCR/ABL1-like B-lineage ALL, and to compare the OS (and RFS) of patients with BCR-ABL-like phenotype with those without BCR-ABL-like phenotype.
II. To evaluate the incidence of anti-blinatumomab antibody formation.
OUTLINE:
INDUCTION CHEMOTHERAPY: Patients receive cytarabine intrathecally (IT) on day 1; daunorubicin hydrochloride intravenously (IV) over 10-15 minutes on days 1, 8, 15, and 22; vincristine sulfate IV on days 1, 8, 15, and 22; dexamethasone orally (PO) daily on days 1-7 (and 15-21 for patients age < 55 years only); methotrexate IT on day 14; pegaspargase intramuscularly (IM) or IV on day 18 (patients age < 55 years); and CD20 positive patients may optionally receive rituximab IV on day 8 and 15. Beginning on day 29, patients with absolute neutrophil count (ANC) >= 0.75 x 10^9/L and platelets > 75 x 10^9/L (patients with delayed hematologic recovery) (patients with residual disease that is delaying count begin treatment immediately) receive cyclophosphamide IV over 30 minutes on days 1 and 29, cytarabine IV over 30 minutes or subcutaneously (SC) on days 1-4, 8-11, 29-32, and 36-39, mercaptopurine PO on days 1-14, 29-42, pegaspargase IM or IV on day 15 (patients age < 55 years), patients receiving treatment for central nervous system (CNS) 2 or 3 leukemia in cycle 1 receive methotrexate IT on days 1, 8, 15, and 22, and CD20 positive patients may optionally receive rituximab IV on days 8 and 15.
INTENSIFICATION THERAPY: Beginning 4 weeks after the completion of cycle 2 of induction therapy, patients receive intensification therapy comprising high-dose methotrexate IV over 2 hours on days 1 and 8, and pegaspargase IM or IV on day 9.
Patients are then randomized to 1 of 2 treatment arms.
Patients randomized to the blinatumomab group receive blinatumomab IV continuously on days 1-28. Treatment repeats every 6 weeks for 2 cycles in the absence of disease progression or unacceptable toxicity. Patients may then undergo allogeneic stem cell transplant (SCT) or proceed to consolidation therapy per investigator discretion.
CONSOLIDATION THERAPY: Beginning after the second cycle of blinatumomab (patients randomized to the blinatumomab group) or after intensification therapy (patients not randomized to blinatumomab), patients receive cytarabine IV over 30 minutes or SC on days 1-5, etoposide IV over 1 hour on days 1-5, methotrexate IT on day 1, and pegaspargase IM or IV on day 5, and CD20 positive patients may optionally receive rituximab IV on day 5. Beginning 4 weeks from day 1 of cycle 1, patients receive cytarabine, etoposide, methotrexate, and CD20 positive patients may receive rituximab as in cycle 1. Beginning 4 weeks from day 1 of cycle 2, patients receive daunorubicin hydrochloride IV over 10-15 minutes on day 1, 8, 15, and 22; vincristine sulfate IV on days 1, 8, 15, and 22; dexamethasone PO daily on days 1-7 (and 15-21 for patients age < 55 years); methotrexate IT on day 2; cyclophosphamide IV over 30 minutes on day 29; cytarabine IV over 30 minutes or SC on days 30-33 and 37-40; mercaptopurine PO on days 29-42 and CD20 positive patients may receive rituximab on day 8. Beginning 8 weeks from day 1 of cycle 3, patients receive cytarabine, etoposide, methotrexate, and CD20 positive patients may optionally receive rituximab as in cycle 1. Patients randomized to blinatumomab repeat cycle 4 and then receive blinatumomab IV continuously on days 1-28.
MAINTENANCE THERAPY: Within 6 weeks after beginning last cycle of consolidation therapy, patients receive mercaptopurine PO daily, methotrexate PO or IV over 2 hours once weekly for 2.5 years, vincristine sulfate IV on day 1 every 3 months, prednisone PO on days 1-5 every 3 months, and methotrexate IT on day 1 every 3 months. Treatment continues for up to 2.5 years in the absence of disease progression or unacceptable toxicity.
Patients undergo x-ray imaging during screening, lumbar puncture while on study, and bone marrow aspiration, bone marrow biopsy, and blood sample collection throughout the study.
After completion of study treatment, patients are followed up every 3 months for 2 years, every 6 months for 3 years, and then every 12 months for 5 years.
Typ studie
Typ studie
Zápis (Aktuální)
Zápis
Fáze
Fáze
- Fáze 3
Kontakty a umístění
Studijní místa
-
-
-
Haifa, Izrael, 31096
- Rambam Medical Center
-
Jerusalem, Izrael, 91031
- Shaare Zedek Medical Center
-
-
-
-
Alberta
-
Calgary, Alberta, Kanada, T2N 5G2
- Arthur J E Child Comprehensive Cancer Centre
-
-
British Columbia
-
Vancouver, British Columbia, Kanada, V5Z 3P1
- Clinical Research Unit at Vancouver Coastal Health Authority
-
-
Nova Scotia
-
Halifax, Nova Scotia, Kanada, B3H 2Y9
- QEII Health Sciences Centre/Nova Scotia Health Authority
-
-
Ontario
-
Kingston, Ontario, Kanada, K7L 2V7
- Kingston Health Sciences Centre
-
-
Quebec
-
Montreal, Quebec, Kanada, H1T 2M4
- CIUSSSEMTL-Hopital Maisonneuve-Rosemont
-
-
Saskatchewan
-
Regina, Saskatchewan, Kanada, S4T 7T1
- Allan Blair Cancer Centre
-
-
-
-
-
Bayamón, Portoriko, 00959-5060
- Cancer Center-Metro Medical Center Bayamon
-
Manati, Portoriko, 00674
- Doctors Cancer Center
-
San Juan, Portoriko, 00917
- San Juan Community Oncology Group
-
San Juan, Portoriko, 00927
- Centro Comprensivo de Cancer de UPR
-
San Juan, Portoriko, 00936
- San Juan City Hospital
-
-
-
-
Alabama
-
Birmingham, Alabama, Spojené státy, 35233
- University of Alabama at Birmingham Cancer Center
-
-
Alaska
-
Anchorage, Alaska, Spojené státy, 98508
- Anchorage Associates in Radiation Medicine
-
Anchorage, Alaska, Spojené státy, 99508
- Alaska Breast Care and Surgery LLC
-
Anchorage, Alaska, Spojené státy, 99508
- Alaska Oncology and Hematology LLC
-
Anchorage, Alaska, Spojené státy, 99508
- Alaska Women's Cancer Care
-
Anchorage, Alaska, Spojené státy, 99508
- Anchorage Oncology Centre
-
Anchorage, Alaska, Spojené státy, 99508
- Katmai Oncology Group
-
Anchorage, Alaska, Spojené státy, 99508
- Providence Alaska Medical Center
-
Anchorage, Alaska, Spojené státy, 99504
- Anchorage Radiation Therapy Center
-
Anchorage, Alaska, Spojené státy, 99508
- Alaska Regional Hospital
-
Fairbanks, Alaska, Spojené státy, 99701
- Fairbanks Memorial Hospital
-
-
Arizona
-
Kingman, Arizona, Spojené státy, 86401
- Kingman Regional Medical Center
-
Tucson, Arizona, Spojené státy, 85719
- Banner University Medical Center - Tucson
-
Tucson, Arizona, Spojené státy, 85719
- University of Arizona Cancer Center-North Campus
-
-
Arkansas
-
Fort Smith, Arkansas, Spojené státy, 72903
- Mercy Hospital Fort Smith
-
Little Rock, Arkansas, Spojené státy, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Arroyo Grande, California, Spojené státy, 93420
- PCR Oncology
-
Burbank, California, Spojené státy, 91505
- Providence Saint Joseph Medical Center/Disney Family Cancer Center
-
Clovis, California, Spojené státy, 93611
- Community Cancer Institute
-
Clovis, California, Spojené státy, 93611
- University Oncology Associates
-
La Jolla, California, Spojené státy, 92093
- UC San Diego Moores Cancer Center
-
Orange, California, Spojené státy, 92868
- UC Irvine Health/Chao Family Comprehensive Cancer Center
-
Palo Alto, California, Spojené státy, 94304
- Stanford Cancer Institute Palo Alto
-
-
Colorado
-
Aurora, Colorado, Spojené státy, 80012
- Rocky Mountain Cancer Centers-Aurora
-
Aurora, Colorado, Spojené státy, 80012
- The Medical Center of Aurora
-
Boulder, Colorado, Spojené státy, 80303
- Boulder Community Foothills Hospital
-
Boulder, Colorado, Spojené státy, 80304
- Rocky Mountain Cancer Centers-Boulder
-
Denver, Colorado, Spojené státy, 80218
- Presbyterian - Saint Lukes Medical Center - Health One
-
Denver, Colorado, Spojené státy, 80220
- Rose Medical Center
-
Denver, Colorado, Spojené státy, 80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver, Colorado, Spojené státy, 80220
- Rocky Mountain Cancer Centers-Rose
-
Denver, Colorado, Spojené státy, 80218
- Colorado Blood Cancer Institute
-
Denver, Colorado, Spojené státy, 80204
- Cancer Center of Colorado at Sloan's Lake
-
Denver, Colorado, Spojené státy, 80209
- The Women's Imaging Center
-
Denver, Colorado, Spojené státy, 80206
- National Jewish Health-Main Campus
-
Denver, Colorado, Spojené státy, 80220
- Western Surgical Care
-
Denver, Colorado, Spojené státy, 80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Englewood, Colorado, Spojené státy, 80113
- Mountain Blue Cancer Care Center - Swedish
-
Englewood, Colorado, Spojené státy, 80113
- Swedish Medical Center
-
Golden, Colorado, Spojené státy, 80401
- National Jewish Health-Western Hematology Oncology
-
Grand Junction, Colorado, Spojené státy, 81501
- Saint Mary's Hospital and Regional Medical Center
-
Grand Junction, Colorado, Spojené státy, 81505
- Grand Valley Oncology
-
Greeley, Colorado, Spojené státy, 80631
- Banner North Colorado Medical Center
-
Lafayette, Colorado, Spojené státy, 80026
- Good Samaritan Hospital - Cancer Centers of Colorado
-
Littleton, Colorado, Spojené státy, 80120
- Rocky Mountain Cancer Centers-Littleton
-
Lone Tree, Colorado, Spojené státy, 80124
- Sky Ridge Medical Center
-
Lone Tree, Colorado, Spojené státy, 80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Loveland, Colorado, Spojené státy, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
Thornton, Colorado, Spojené státy, 80260
- National Jewish Health-Northern Hematology Oncology
-
Wheat Ridge, Colorado, Spojené státy, 80401
- Intermountain Health Lutheran Hospital
-
-
Connecticut
-
Hartford, Connecticut, Spojené státy, 06105
- Smilow Cancer Hospital Care Center at Saint Francis
-
New Haven, Connecticut, Spojené státy, 06520
- Yale University
-
Torrington, Connecticut, Spojené státy, 06790
- Smilow Cancer Hospital-Torrington Care Center
-
-
District of Columbia
-
Washington D.C., District of Columbia, Spojené státy, 20016
- Sibley Memorial Hospital
-
-
Florida
-
Coral Springs, Florida, Spojené státy, 33065
- UM Sylvester Comprehensive Cancer Center at Coral Springs
-
Deerfield Beach, Florida, Spojené státy, 33442
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach
-
Hollywood, Florida, Spojené státy, 33021
- UM Sylvester Comprehensive Cancer Center at Hollywood
-
Jacksonville, Florida, Spojené státy, 32207
- Baptist MD Anderson Cancer Center
-
Miami, Florida, Spojené státy, 33136
- University of Miami Miller School of Medicine-Sylvester Cancer Center
-
Miami, Florida, Spojené státy, 33176
- UM Sylvester Comprehensive Cancer Center at Kendall
-
Plantation, Florida, Spojené státy, 33324
- UM Sylvester Comprehensive Cancer Center at Plantation
-
Weston, Florida, Spojené státy, 33331
- Cleveland Clinic-Weston
-
-
Georgia
-
Atlanta, Georgia, Spojené státy, 30322
- Emory University Hospital/Winship Cancer Institute
-
Atlanta, Georgia, Spojené státy, 30342
- Northside Hospital
-
-
Idaho
-
Boise, Idaho, Spojené státy, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise, Idaho, Spojené státy, 83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell, Idaho, Spojené státy, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Coeur d'Alene, Idaho, Spojené státy, 83814
- Kootenai Health - Coeur d'Alene
-
Emmett, Idaho, Spojené státy, 83617
- Walter Knox Memorial Hospital
-
Fruitland, Idaho, Spojené státy, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, Spojené státy, 83642
- Idaho Urologic Institute-Meridian
-
Meridian, Idaho, Spojené státy, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, Spojené státy, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
Nampa, Idaho, Spojené státy, 83687
- Saint Luke's Cancer Institute - Nampa
-
Post Falls, Idaho, Spojené státy, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint, Idaho, Spojené státy, 83864
- Kootenai Clinic Cancer Services - Sandpoint
-
Twin Falls, Idaho, Spojené státy, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Bloomington, Illinois, Spojené státy, 61704
- Illinois CancerCare-Bloomington
-
Bloomington, Illinois, Spojené státy, 61701
- OSF Saint Joseph Medical Center
-
Canton, Illinois, Spojené státy, 61520
- Illinois CancerCare-Canton
-
Carbondale, Illinois, Spojené státy, 62902
- Memorial Hospital of Carbondale
-
Carterville, Illinois, Spojené státy, 62918
- SIH Cancer Institute
-
Carthage, Illinois, Spojené státy, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Spojené státy, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Spojené státy, 60611
- Northwestern University
-
Chicago, Illinois, Spojené státy, 60637
- University of Chicago Comprehensive Cancer Center
-
Chicago, Illinois, Spojené státy, 60612
- University of Illinois
-
Chicago, Illinois, Spojené státy, 60608
- Mount Sinai Hospital Medical Center
-
Decatur, Illinois, Spojené státy, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Spojené státy, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Dixon, Illinois, Spojené státy, 61021
- Illinois CancerCare-Dixon
-
Effingham, Illinois, Spojené státy, 62401
- Crossroads Cancer Center
-
Eureka, Illinois, Spojené státy, 61530
- Illinois CancerCare-Eureka
-
Evanston, Illinois, Spojené státy, 60201
- NorthShore University HealthSystem-Evanston Hospital
-
Galesburg, Illinois, Spojené státy, 61401
- Western Illinois Cancer Treatment Center
-
Galesburg, Illinois, Spojené státy, 61401
- Illinois CancerCare-Galesburg
-
Glenview, Illinois, Spojené státy, 60026
- NorthShore University HealthSystem-Glenbrook Hospital
-
Highland Park, Illinois, Spojené státy, 60035
- NorthShore University HealthSystem-Highland Park Hospital
-
Highland Park, Illinois, Spojené státy, 60035
- Hematology Oncology Associates of Illinois-Highland Park
-
Kankakee, Illinois, Spojené státy, 60901
- Presence Saint Mary's Hospital
-
Kewanee, Illinois, Spojené státy, 61443
- Illinois CancerCare-Kewanee Clinic
-
Libertyville, Illinois, Spojené státy, 60048
- AMG Libertyville - Oncology
-
Macomb, Illinois, Spojené státy, 61455
- Illinois CancerCare-Macomb
-
Maywood, Illinois, Spojené státy, 60153
- Loyola University Medical Center
-
Mount Vernon, Illinois, Spojené státy, 62864
- SSM Health Good Samaritan
-
Niles, Illinois, Spojené státy, 60714
- Illinois Cancer Specialists-Niles
-
O'Fallon, Illinois, Spojené státy, 62269
- Cancer Care Center of O'Fallon
-
Ottawa, Illinois, Spojené státy, 61350
- Illinois CancerCare-Ottawa Clinic
-
Ottawa, Illinois, Spojené státy, 61350
- Radiation Oncology of Northern Illinois
-
Pekin, Illinois, Spojené státy, 61554
- Illinois CancerCare-Pekin
-
Pekin, Illinois, Spojené státy, 61554
- OSF Saint Francis Radiation Oncology at Pekin
-
Peoria, Illinois, Spojené státy, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Spojené státy, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, Spojené státy, 61615
- Illinois CancerCare-Peoria
-
Peoria, Illinois, Spojené státy, 61615
- OSF Saint Francis Radiation Oncology at Peoria Cancer Center
-
Peru, Illinois, Spojené státy, 61354
- Illinois CancerCare-Peru
-
Peru, Illinois, Spojené státy, 61354
- Valley Radiation Oncology
-
Princeton, Illinois, Spojené státy, 61356
- Illinois CancerCare-Princeton
-
Skokie, Illinois, Spojené státy, 60076
- Hematology Oncology Associates of Illinois - Skokie
-
Skokie, Illinois, Spojené státy, 60076
- North Shore Medical Center
-
Springfield, Illinois, Spojené státy, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Spojené státy, 62702
- Springfield Clinic
-
Springfield, Illinois, Spojené státy, 62702
- Central Illinois Hematology Oncology Center
-
Springfield, Illinois, Spojené státy, 62781
- Springfield Memorial Hospital
-
Swansea, Illinois, Spojené státy, 62226
- Southwest Illinois Health Services LLP
-
-
Indiana
-
Fort Wayne, Indiana, Spojené státy, 46805
- Parkview Hospital Randallia
-
Fort Wayne, Indiana, Spojené státy, 46845
- Parkview Regional Medical Center
-
Indianapolis, Indiana, Spojené státy, 46237
- Franciscan Health Indianapolis
-
Mooresville, Indiana, Spojené státy, 46158
- Franciscan Health Mooresville
-
Richmond, Indiana, Spojené státy, 47374
- Reid Health
-
-
Iowa
-
Ames, Iowa, Spojené státy, 50010
- Mary Greeley Medical Center
-
Ames, Iowa, Spojené státy, 50010
- McFarland Clinic - Ames
-
Boone, Iowa, Spojené státy, 50036
- McFarland Clinic - Boone
-
Fort Dodge, Iowa, Spojené státy, 50501
- McFarland Clinic - Trinity Cancer Center
-
Jefferson, Iowa, Spojené státy, 50129
- McFarland Clinic - Jefferson
-
Marshalltown, Iowa, Spojené státy, 50158
- McFarland Clinic - Marshalltown
-
-
Kansas
-
Chanute, Kansas, Spojené státy, 66720
- Cancer Center of Kansas - Chanute
-
Dodge City, Kansas, Spojené státy, 67801
- Cancer Center of Kansas - Dodge City
-
El Dorado, Kansas, Spojené státy, 67042
- Cancer Center of Kansas - El Dorado
-
Fort Scott, Kansas, Spojené státy, 66701
- Cancer Center of Kansas - Fort Scott
-
Garden City, Kansas, Spojené státy, 67846
- Central Care Cancer Center - Garden City
-
Great Bend, Kansas, Spojené státy, 67530
- Central Care Cancer Center - Great Bend
-
Independence, Kansas, Spojené státy, 67301
- Cancer Center of Kansas-Independence
-
Kansas City, Kansas, Spojené státy, 66160
- University of Kansas Cancer Center
-
Kingman, Kansas, Spojené státy, 67068
- Cancer Center of Kansas-Kingman
-
Lawrence, Kansas, Spojené státy, 66044
- Lawrence Memorial Hospital
-
Lenexa, Kansas, Spojené státy, 66219
- Kansas Institute of Medicine Cancer and Blood Center
-
Lenexa, Kansas, Spojené státy, 66219
- Minimally Invasive Surgery Hospital
-
Liberal, Kansas, Spojené státy, 67905
- Cancer Center of Kansas-Liberal
-
Manhattan, Kansas, Spojené státy, 66502
- Cancer Center of Kansas-Manhattan
-
McPherson, Kansas, Spojené státy, 67460
- Cancer Center of Kansas - McPherson
-
Newton, Kansas, Spojené státy, 67114
- Cancer Center of Kansas - Newton
-
Olathe, Kansas, Spojené státy, 66061
- The University of Kansas Cancer Center - Olathe
-
Overland Park, Kansas, Spojené státy, 66209
- Menorah Medical Center
-
Overland Park, Kansas, Spojené státy, 66213
- Saint Luke's South Hospital
-
Parsons, Kansas, Spojené státy, 67357
- Cancer Center of Kansas - Parsons
-
Pratt, Kansas, Spojené státy, 67124
- Cancer Center of Kansas - Pratt
-
Salina, Kansas, Spojené státy, 67401
- Cancer Center of Kansas - Salina
-
Wellington, Kansas, Spojené státy, 67152
- Cancer Center of Kansas - Wellington
-
Westwood, Kansas, Spojené státy, 66205
- University of Kansas Hospital-Westwood Cancer Center
-
Wichita, Kansas, Spojené státy, 67214
- Ascension Via Christi Hospitals Wichita
-
Wichita, Kansas, Spojené státy, 67208
- Cancer Center of Kansas-Wichita Medical Arts Tower
-
Wichita, Kansas, Spojené státy, 67214
- Cancer Center of Kansas - Wichita
-
Wichita, Kansas, Spojené státy, 67208
- Associates In Womens Health
-
Wichita, Kansas, Spojené státy, 67214
- Wesley Medical Center
-
Winfield, Kansas, Spojené státy, 67156
- Cancer Center of Kansas - Winfield
-
-
Kentucky
-
Crestview Hills, Kentucky, Spojené státy, 41017
- Oncology Hematology Care Inc-Crestview
-
Louisville, Kentucky, Spojené státy, 40202
- The James Graham Brown Cancer Center at University of Louisville
-
-
Louisiana
-
Baton Rouge, Louisiana, Spojené státy, 70809
- Ochsner Health Center-Summa
-
Baton Rouge, Louisiana, Spojené státy, 70816
- Medical Center of Baton Rouge
-
Baton Rouge, Louisiana, Spojené státy, 70836
- Ochsner High Grove
-
Monroe, Louisiana, Spojené státy, 71202
- Ochsner LSU Health Monroe Medical Center
-
New Orleans, Louisiana, Spojené státy, 70121
- Ochsner Medical Center Jefferson
-
Shreveport, Louisiana, Spojené státy, 71103
- LSU Health Sciences Center at Shreveport
-
-
Maine
-
Bangor, Maine, Spojené státy, 04401
- Eastern Maine Medical Center
-
Brewer, Maine, Spojené státy, 04412
- Lafayette Family Cancer Center-EMMC
-
-
Maryland
-
Baltimore, Maryland, Spojené státy, 21287
- Johns Hopkins University/Sidney Kimmel Cancer Center
-
Baltimore, Maryland, Spojené státy, 21201
- University of Maryland/Greenebaum Cancer Center
-
Bethesda, Maryland, Spojené státy, 20889-5600
- Walter Reed National Military Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, Spojené státy, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, Spojené státy, 02215
- Dana-Farber Cancer Institute
-
Boston, Massachusetts, Spojené státy, 02114
- Massachusetts General Hospital Cancer Center
-
-
Michigan
-
Adrian, Michigan, Spojené státy, 49221
- Bixby Medical Center
-
Adrian, Michigan, Spojené státy, 49221
- Hickman Cancer Center
-
Ann Arbor, Michigan, Spojené státy, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Battle Creek, Michigan, Spojené státy, 49017
- Bronson Battle Creek
-
Brownstown, Michigan, Spojené státy, 48183
- Henry Ford Cancer Institute-Downriver
-
Clinton Township, Michigan, Spojené státy, 48038
- Henry Ford Macomb Hospital-Clinton Township
-
Dearborn, Michigan, Spojené státy, 48126
- Henry Ford Medical Center-Fairlane
-
Dearborn, Michigan, Spojené státy, 48124
- Corewell Health Dearborn Hospital
-
Detroit, Michigan, Spojené státy, 48202
- Henry Ford Hospital
-
Detroit, Michigan, Spojené státy, 48201
- Wayne State University/Karmanos Cancer Institute
-
Detroit, Michigan, Spojené státy, 48236
- Henry Ford Health Saint John Hospital
-
Escanaba, Michigan, Spojené státy, 49829
- OSF Saint Francis Hospital and Medical Group
-
Farmington Hills, Michigan, Spojené státy, 48334
- Weisberg Cancer Treatment Center
-
Farmington Hills, Michigan, Spojené státy, 48336
- Corewell Health Farmington Hills Hospital
-
Flint, Michigan, Spojené státy, 48503
- Hurley Medical Center
-
Flint, Michigan, Spojené státy, 48503
- Genesys Hurley Cancer Institute
-
Grand Rapids, Michigan, Spojené státy, 49503
- Trinity Health Grand Rapids Hospital
-
Grand Rapids, Michigan, Spojené státy, 49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Grand Rapids, Michigan, Spojené státy, 49503
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
-
Grosse Pointe, Michigan, Spojené státy, 48230
- William Beaumont Hospital-Grosse Pointe
-
Jackson, Michigan, Spojené státy, 49201
- Allegiance Health
-
Kalamazoo, Michigan, Spojené státy, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Spojené státy, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Spojené státy, 49048
- Beacon Kalamazoo
-
Lansing, Michigan, Spojené státy, 48912
- University of Michigan Health - Sparrow Lansing
-
Livonia, Michigan, Spojené státy, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Monroe, Michigan, Spojené státy, 48162
- Mercy Memorial Hospital
-
Monroe, Michigan, Spojené státy, 48162
- Toledo Clinic Cancer Centers-Monroe
-
Muskegon, Michigan, Spojené státy, 49444
- Trinity Health Muskegon Hospital
-
Niles, Michigan, Spojené státy, 49120
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Norton Shores, Michigan, Spojené státy, 49444
- Cancer and Hematology Centers of Western Michigan - Norton Shores
-
Novi, Michigan, Spojené státy, 48377
- Henry Ford Medical Center-Columbus
-
Pontiac, Michigan, Spojené státy, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Port Huron, Michigan, Spojené státy, 48060
- Lake Huron Medical Center
-
Port Huron, Michigan, Spojené státy, 48060
- Huron Medical Center PC
-
Reed City, Michigan, Spojené státy, 49677
- Corewell Health Reed City Hospital
-
Roseville, Michigan, Spojené státy, 48066
- Michigan Cancer Specialists
-
Royal Oak, Michigan, Spojené státy, 48073
- Cancer Care Associates PC
-
Royal Oak, Michigan, Spojené státy, 48073
- Comprehensive Medical Center PLLC
-
Royal Oak, Michigan, Spojené státy, 48073
- Oakland Medical Group
-
Royal Oak, Michigan, Spojené státy, 48067
- Oakland Colon Rectal Associates
-
Royal Oak, Michigan, Spojené státy, 48073
- Hematology Oncology Consultants PC-Royal Oak
-
Royal Oak, Michigan, Spojené státy, 48073
- Corewell Health William Beaumont University Hospital
-
Saginaw, Michigan, Spojené státy, 48601
- MyMichigan Medical Center Saginaw
-
Saint Joseph, Michigan, Spojené státy, 49085
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Saint Joseph, Michigan, Spojené státy, 49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Sterling Heights, Michigan, Spojené státy, 48312
- Premier Hematology Oncology Care
-
Sterling Heights, Michigan, Spojené státy, 48314
- Mitchell Folbe MD PC
-
Traverse City, Michigan, Spojené státy, 49684
- Munson Medical Center
-
Troy, Michigan, Spojené státy, 48084
- Michigan Institute of Urology-Town Center
-
Troy, Michigan, Spojené státy, 48085
- Claudia BR Herke MD PC
-
Troy, Michigan, Spojené státy, 48098
- Hematology Oncology Consultants PC-Troy
-
Troy, Michigan, Spojené státy, 48085
- Corewell Health Beaumont Troy Hospital
-
Warren, Michigan, Spojené státy, 48093
- Henry Ford Health Warren Hospital
-
West Bloomfield, Michigan, Spojené státy, 48322
- Henry Ford West Bloomfield Hospital
-
Wyoming, Michigan, Spojené státy, 49519
- University of Michigan Health - West
-
-
Minnesota
-
Rochester, Minnesota, Spojené státy, 55905
- Mayo Clinic in Rochester
-
-
Missouri
-
Ballwin, Missouri, Spojené státy, 63011
- Mercy Oncology and Hematology - Clayton-Clarkson
-
Bolivar, Missouri, Spojené státy, 65613
- Central Care Cancer Center - Bolivar
-
Bonne Terre, Missouri, Spojené státy, 63628
- Parkland Health Center-Bonne Terre
-
Branson, Missouri, Spojené státy, 65616
- Cox Cancer Center Branson
-
Cape Girardeau, Missouri, Spojené státy, 63703
- Saint Francis Medical Center
-
Cape Girardeau, Missouri, Spojené státy, 63703
- Mercy Cancer Center - Cape Girardeau
-
City of Saint Peters, Missouri, Spojené státy, 63376
- Siteman Cancer Center at Saint Peters Hospital
-
Creve Coeur, Missouri, Spojené státy, 63141
- Siteman Cancer Center at West County Hospital
-
Farmington, Missouri, Spojené státy, 63640
- Parkland Health Center - Farmington
-
Independence, Missouri, Spojené státy, 64057
- Centerpoint Medical Center LLC
-
Jefferson City, Missouri, Spojené státy, 65109
- MU Health Care Goldschmidt Cancer Center
-
Joplin, Missouri, Spojené státy, 64804
- Freeman Health System
-
Joplin, Missouri, Spojené státy, 64804
- Mercy Hospital Joplin
-
Kansas City, Missouri, Spojené státy, 64111
- Saint Luke's Hospital of Kansas City
-
Kansas City, Missouri, Spojené státy, 64132
- Research Medical Center
-
Kansas City, Missouri, Spojené státy, 64118
- Heartland Hematology and Oncology Associates Incorporated
-
Lee's Summit, Missouri, Spojené státy, 64086
- Saint Luke's East - Lee's Summit
-
Liberty, Missouri, Spojené státy, 64068
- Liberty Hospital
-
Rolla, Missouri, Spojené státy, 65401
- Mercy Clinic-Rolla-Cancer and Hematology
-
Rolla, Missouri, Spojené státy, 65401
- Phelps Health Delbert Day Cancer Institute
-
Saint Joseph, Missouri, Spojené státy, 64506
- Heartland Regional Medical Center
-
Sainte Genevieve, Missouri, Spojené státy, 63670
- Sainte Genevieve County Memorial Hospital
-
Springfield, Missouri, Spojené státy, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Spojené státy, 65804
- Mercy Hospital Springfield
-
St Louis, Missouri, Spojené státy, 63110
- Washington University School of Medicine
-
St Louis, Missouri, Spojené státy, 63129
- Siteman Cancer Center-South County
-
St Louis, Missouri, Spojené státy, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, Spojené státy, 63109
- Mercy Infusion Center - Chippewa
-
St Louis, Missouri, Spojené státy, 63141
- Mercy Hospital Saint Louis
-
St Louis, Missouri, Spojené státy, 63128
- Mercy Hospital South
-
Sullivan, Missouri, Spojené státy, 63080
- Missouri Baptist Sullivan Hospital
-
Washington, Missouri, Spojené státy, 63090
- Mercy Hospital Washington
-
-
Montana
-
Anaconda, Montana, Spojené státy, 59711
- Community Hospital of Anaconda
-
Billings, Montana, Spojené státy, 59101
- Billings Clinic Cancer Center
-
Billings, Montana, Spojené státy, 59101
- Saint Vincent Healthcare
-
Billings, Montana, Spojené státy, 59102
- Saint Vincent Frontier Cancer Center
-
Bozeman, Montana, Spojené státy, 59715
- Bozeman Health Deaconess Hospital
-
Butte, Montana, Spojené státy, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, Spojené státy, 59405
- Great Falls Clinic
-
Great Falls, Montana, Spojené státy, 59405
- Benefis Sletten Cancer Institute
-
Helena, Montana, Spojené státy, 59601
- Saint Peter's Community Hospital
-
Kalispell, Montana, Spojené státy, 59901
- Logan Health Medical Center
-
Missoula, Montana, Spojené státy, 59802
- Saint Patrick Hospital - Community Hospital
-
Missoula, Montana, Spojené státy, 59804
- Community Medical Center
-
-
Nebraska
-
Bellevue, Nebraska, Spojené státy, 68123
- Nebraska Medicine-Bellevue
-
Omaha, Nebraska, Spojené státy, 68198
- University of Nebraska Medical Center
-
Omaha, Nebraska, Spojené státy, 68118
- Nebraska Medicine-Village Pointe
-
-
Nevada
-
Carson City, Nevada, Spojené státy, 89703
- Carson Tahoe Regional Medical Center
-
Henderson, Nevada, Spojené státy, 89052
- Comprehensive Cancer Centers of Nevada - Henderson
-
Henderson, Nevada, Spojené státy, 89052
- Cancer and Blood Specialists-Henderson
-
Henderson, Nevada, Spojené státy, 89052
- Las Vegas Cancer Center-Henderson
-
Henderson, Nevada, Spojené státy, 89074
- Comprehensive Cancer Centers of Nevada-Southeast Henderson
-
Henderson, Nevada, Spojené státy, 89052
- Comprehensive Cancer Centers of Nevada-Horizon Ridge
-
Henderson, Nevada, Spojené státy, 89074
- Las Vegas Urology - Green Valley
-
Henderson, Nevada, Spojené státy, 89074
- Las Vegas Urology - Pebble
-
Henderson, Nevada, Spojené státy, 89074
- Urology Specialists of Nevada - Green Valley
-
Henderson, Nevada, Spojené státy, 89074
- Oncology Las Vegas - Henderson
-
Las Vegas, Nevada, Spojené státy, 89144
- Summerlin Hospital Medical Center
-
Las Vegas, Nevada, Spojené státy, 89109
- Sunrise Hospital and Medical Center
-
Las Vegas, Nevada, Spojené státy, 89102
- OptumCare Cancer Care at Charleston
-
Las Vegas, Nevada, Spojené státy, 89106
- Radiation Oncology Centers of Nevada Central
-
Las Vegas, Nevada, Spojené státy, 89119
- Radiation Oncology Centers of Nevada Southeast
-
Las Vegas, Nevada, Spojené státy, 89128
- Comprehensive Cancer Centers of Nevada - Northwest
-
Las Vegas, Nevada, Spojené státy, 89128
- OptumCare Cancer Care at MountainView
-
Las Vegas, Nevada, Spojené státy, 89135
- Alliance for Childhood Diseases/Cure 4 the Kids Foundation
-
Las Vegas, Nevada, Spojené státy, 89144
- Comprehensive Cancer Centers of Nevada - Town Center
-
Las Vegas, Nevada, Spojené státy, 89144
- Comprehensive Cancer Centers of Nevada-Summerlin
-
Las Vegas, Nevada, Spojené státy, 89148
- Comprehensive Cancer Centers of Nevada
-
Las Vegas, Nevada, Spojené státy, 89169
- Comprehensive Cancer Centers of Nevada - Central Valley
-
Las Vegas, Nevada, Spojené státy, 89102
- University Medical Center of Southern Nevada
-
Las Vegas, Nevada, Spojené státy, 89106
- Cancer and Blood Specialists-Shadow
-
Las Vegas, Nevada, Spojené státy, 89109
- HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
-
Las Vegas, Nevada, Spojené státy, 89113
- HealthCare Partners Medical Group Oncology/Hematology-San Martin
-
Las Vegas, Nevada, Spojené státy, 89121
- Cancer Therapy and Integrative Medicine
-
Las Vegas, Nevada, Spojené státy, 89128
- Cancer and Blood Specialists-Tenaya
-
Las Vegas, Nevada, Spojené státy, 89128
- HealthCare Partners Medical Group Oncology/Hematology-Tenaya
-
Las Vegas, Nevada, Spojené státy, 89148-2405
- Las Vegas Cancer Center-Medical Center
-
Las Vegas, Nevada, Spojené státy, 89149
- HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
-
Las Vegas, Nevada, Spojené státy, 89128
- Ann M Wierman MD LTD
-
Las Vegas, Nevada, Spojené státy, 89074
- Las Vegas Urology - Pecos
-
Las Vegas, Nevada, Spojené státy, 89102
- Desert West Surgery
-
Las Vegas, Nevada, Spojené státy, 89103
- Hope Cancer Care of Nevada
-
Las Vegas, Nevada, Spojené státy, 89106
- Urology Specialists of Nevada - Central
-
Las Vegas, Nevada, Spojené státy, 89113
- Las Vegas Prostate Cancer Center
-
Las Vegas, Nevada, Spojené státy, 89113
- Las Vegas Urology - Sunset
-
Las Vegas, Nevada, Spojené státy, 89128
- Las Vegas Urology - Cathedral Rock
-
Las Vegas, Nevada, Spojené státy, 89128
- Las Vegas Urology - Smoke Ranch
-
Las Vegas, Nevada, Spojené státy, 89128
- Urology Specialists of Nevada - Northwest
-
Las Vegas, Nevada, Spojené státy, 89169
- University Cancer Center
-
Las Vegas, Nevada, Spojené státy, 89113
- Urology Specialists of Nevada - Southwest
-
Las Vegas, Nevada, Spojené státy, 89128
- Oncology Las Vegas - Tenaya
-
Las Vegas, Nevada, Spojené státy, 89183
- OptumCare Cancer Care at Fort Apache
-
Pahrump, Nevada, Spojené státy, 89048
- Hope Cancer Care of Nevada-Pahrump
-
Reno, Nevada, Spojené státy, 89502
- Renown Regional Medical Center
-
Reno, Nevada, Spojené státy, 89503
- Saint Mary's Regional Medical Center
-
Reno, Nevada, Spojené státy, 89509
- Radiation Oncology Associates
-
-
New Hampshire
-
Lebanon, New Hampshire, Spojené státy, 03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
-
New Jersey
-
Basking Ridge, New Jersey, Spojené státy, 07920
- Memorial Sloan Kettering Basking Ridge
-
Middletown, New Jersey, Spojené státy, 07748
- Memorial Sloan Kettering Monmouth
-
Montvale, New Jersey, Spojené státy, 07645
- Memorial Sloan Kettering Bergen
-
New Brunswick, New Jersey, Spojené státy, 08903
- Rutgers Cancer Institute of New Jersey
-
-
New York
-
Buffalo, New York, Spojené státy, 14263
- Roswell Park Cancer Institute
-
Commack, New York, Spojené státy, 11725
- Memorial Sloan Kettering Commack
-
Harrison, New York, Spojené státy, 10604
- Memorial Sloan Kettering Westchester
-
Lake Success, New York, Spojené státy, 11042
- Northwell Health/Center for Advanced Medicine
-
Manhasset, New York, Spojené státy, 11030
- North Shore University Hospital
-
New Hyde Park, New York, Spojené státy, 11040
- Long Island Jewish Medical Center
-
New York, New York, Spojené státy, 10065
- Memorial Sloan Kettering Cancer Center
-
Rochester, New York, Spojené státy, 14642
- University of Rochester
-
Stony Brook, New York, Spojené státy, 11794
- Stony Brook University Medical Center
-
The Bronx, New York, Spojené státy, 10461
- Montefiore Medical Center-Einstein Campus
-
The Bronx, New York, Spojené státy, 10467
- Montefiore Medical Center - Moses Campus
-
The Bronx, New York, Spojené státy, 10461
- Montefiore Medical Center-Weiler Hospital
-
Uniondale, New York, Spojené státy, 11553
- Memorial Sloan Kettering Nassau
-
-
North Carolina
-
Asheville, North Carolina, Spojené státy, 28803
- AdventHealth Infusion Center Asheville
-
Chapel Hill, North Carolina, Spojené státy, 27599
- UNC Lineberger Comprehensive Cancer Center
-
Clyde, North Carolina, Spojené státy, 28721
- AdventHealth Infusion Center Haywood
-
Hendersonville, North Carolina, Spojené státy, 28792
- AdventHealth Hendersonville
-
Winston-Salem, North Carolina, Spojené státy, 27157
- Wake Forest University Health Sciences
-
-
Ohio
-
Beavercreek, Ohio, Spojené státy, 45431
- Indu and Raj Soin Medical Center
-
Boardman, Ohio, Spojené státy, 44512
- Saint Elizabeth Boardman Hospital
-
Bowling Green, Ohio, Spojené státy, 43402
- Toledo Clinic Cancer Centers-Bowling Green
-
Centerville, Ohio, Spojené státy, 45459
- Miami Valley Hospital South
-
Centerville, Ohio, Spojené státy, 45459
- Dayton Physicians LLC-Miami Valley South
-
Cincinnati, Ohio, Spojené státy, 45219
- University of Cincinnati Cancer Center-UC Medical Center
-
Cincinnati, Ohio, Spojené státy, 45242
- Oncology Hematology Care Inc-Blue Ash
-
Cincinnati, Ohio, Spojené státy, 45202
- Oncology Hematology Care Inc-Eden Park
-
Cincinnati, Ohio, Spojené státy, 45211
- Oncology Hematology Care Inc-Mercy West
-
Cincinnati, Ohio, Spojené státy, 45230
- Oncology Hematology Care Inc-Anderson
-
Cincinnati, Ohio, Spojené státy, 45236
- Oncology Hematology Care Inc-Kenwood
-
Cleveland, Ohio, Spojené státy, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Spojené státy, 44195
- Cleveland Clinic Foundation
-
Columbus, Ohio, Spojené státy, 43210
- Ohio State University Comprehensive Cancer Center
-
Dayton, Ohio, Spojené státy, 45406
- Good Samaritan Hospital - Dayton
-
Dayton, Ohio, Spojené státy, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Spojené státy, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, Spojené státy, 45415
- Dayton Physician LLC - Englewood
-
Fairfield, Ohio, Spojené státy, 45014
- Oncology Hematology Care Inc-Healthplex
-
Findlay, Ohio, Spojené státy, 45840
- Blanchard Valley Hospital
-
Findlay, Ohio, Spojené státy, 45840
- Armes Family Cancer Center
-
Findlay, Ohio, Spojené státy, 45840
- Orion Cancer Care
-
Franklin, Ohio, Spojené státy, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Franklin, Ohio, Spojené státy, 45005
- Dayton Physicians LLC-Atrium
-
Greenville, Ohio, Spojené státy, 45331
- Wayne Hospital
-
Greenville, Ohio, Spojené státy, 45331
- Dayton Physicians LLC-Wayne
-
Kettering, Ohio, Spojené státy, 45429
- Kettering Medical Center
-
Kettering, Ohio, Spojené státy, 45409
- Greater Dayton Cancer Center
-
Kettering, Ohio, Spojené státy, 45420
- First Dayton Cancer Care
-
Lima, Ohio, Spojené státy, 45804
- Lima Memorial Hospital
-
Maumee, Ohio, Spojené státy, 43537
- Toledo Clinic Cancer Centers-Maumee
-
Maumee, Ohio, Spojené státy, 43537
- Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
-
Middletown, Ohio, Spojené státy, 45042
- Dayton Physicians LLC-Signal Point
-
Oregon, Ohio, Spojené státy, 43616
- Saint Charles Hospital
-
Oregon, Ohio, Spojené státy, 43616
- Toledo Clinic Cancer Centers-Oregon
-
Sidney, Ohio, Spojené státy, 45365
- Dayton Physicians LLC-Wilson
-
Springfield, Ohio, Spojené státy, 45504
- Springfield Regional Cancer Center
-
Springfield, Ohio, Spojené státy, 45504
- Springfield Regional Medical Center
-
Sylvania, Ohio, Spojené státy, 43560
- ProMedica Flower Hospital
-
Tiffin, Ohio, Spojené státy, 44883
- Mercy Hospital of Tiffin
-
Toledo, Ohio, Spojené státy, 43606
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
-
Toledo, Ohio, Spojené státy, 43623
- Mercy Health - Saint Anne Hospital
-
Toledo, Ohio, Spojené státy, 43623
- Toledo Clinic Cancer Centers-Toledo
-
Toledo, Ohio, Spojené státy, 43614
- University of Toledo
-
Toledo, Ohio, Spojené státy, 43617
- Toledo Community Hospital Oncology Program CCOP
-
Toledo, Ohio, Spojené státy, 43608
- Mercy Health - Saint Vincent Hospital
-
Troy, Ohio, Spojené státy, 45373
- Upper Valley Medical Center
-
Troy, Ohio, Spojené státy, 45373
- Dayton Physicians LLC - Troy
-
Warren, Ohio, Spojené státy, 44484
- Saint Joseph Warren Hospital
-
Wauseon, Ohio, Spojené státy, 43567
- Fulton County Health Center
-
West Chester, Ohio, Spojené státy, 45069
- University of Cincinnati Cancer Center-West Chester
-
Wright-Patterson Air Force Base, Ohio, Spojené státy, 45433
- Wright-Patterson Medical Center
-
Youngstown, Ohio, Spojené státy, 44501
- Saint Elizabeth Youngstown Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Spojené státy, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, Spojené státy, 73120
- Mercy Hospital Oklahoma City
-
-
Oregon
-
Baker City, Oregon, Spojené státy, 97814
- Saint Alphonsus Cancer Care Center-Baker City
-
Bend, Oregon, Spojené státy, 97701
- Saint Charles Health System
-
Clackamas, Oregon, Spojené státy, 97015
- Clackamas Radiation Oncology Center
-
Clackamas, Oregon, Spojené státy, 97015
- Providence Cancer Institute Clackamas Clinic
-
Coos Bay, Oregon, Spojené státy, 97420
- Bay Area Hospital
-
Newberg, Oregon, Spojené státy, 97132
- Providence Newberg Medical Center
-
Ontario, Oregon, Spojené státy, 97914
- Saint Alphonsus Cancer Care Center-Ontario
-
Oregon City, Oregon, Spojené státy, 97045
- Providence Willamette Falls Medical Center
-
Portland, Oregon, Spojené státy, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Spojené státy, 97225
- Providence Saint Vincent Medical Center
-
Redmond, Oregon, Spojené státy, 97756
- Saint Charles Health System-Redmond
-
-
Pennsylvania
-
Danville, Pennsylvania, Spojené státy, 17822
- Geisinger Medical Center
-
Hershey, Pennsylvania, Spojené státy, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Philadelphia, Pennsylvania, Spojené státy, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Spojené státy, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, Spojené státy, 19104
- University of Pennsylvania/Abramson Cancer Center
-
Pittsburgh, Pennsylvania, Spojené státy, 15232
- UPMC Hillman Cancer Center
-
Scranton, Pennsylvania, Spojené státy, 18510
- Community Medical Center
-
-
South Carolina
-
Anderson, South Carolina, Spojené státy, 29621
- AnMed Health Cancer Center
-
Boiling Springs, South Carolina, Spojené státy, 29316
- Prisma Health Cancer Institute - Spartanburg
-
Easley, South Carolina, Spojené státy, 29640
- Prisma Health Cancer Institute - Easley
-
Gaffney, South Carolina, Spojené státy, 29341
- Gibbs Cancer Center-Gaffney
-
Greenville, South Carolina, Spojené státy, 29605
- Prisma Health Cancer Institute - Faris
-
Greenville, South Carolina, Spojené státy, 29607
- Saint Francis Cancer Center
-
Greenville, South Carolina, Spojené státy, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenville, South Carolina, Spojené státy, 29605
- Prisma Health Cancer Institute - Butternut
-
Greenville, South Carolina, Spojené státy, 29601
- Saint Francis Hospital
-
Greenville, South Carolina, Spojené státy, 29605
- Prisma Health Greenville Memorial Hospital
-
Greenville, South Carolina, Spojené státy, 29601
- Greenville Health System Cancer Institute-Andrews
-
Greer, South Carolina, Spojené státy, 29650
- Prisma Health Cancer Institute - Greer
-
Greer, South Carolina, Spojené státy, 29651
- Gibbs Cancer Center-Pelham
-
Lancaster, South Carolina, Spojené státy, 29720
- Carolina Blood and Cancer Care Associates PA-Lancaster
-
Rock Hill, South Carolina, Spojené státy, 29732
- Carolina Blood and Cancer Care Associates PA
-
Seneca, South Carolina, Spojené státy, 29672
- Prisma Health Cancer Institute - Seneca
-
Spartanburg, South Carolina, Spojené státy, 29303
- Spartanburg Medical Center
-
-
Tennessee
-
Franklin, Tennessee, Spojené státy, 37067
- Vanderbilt-Ingram Cancer Center Cool Springs
-
Nashville, Tennessee, Spojené státy, 37232
- Vanderbilt University/Ingram Cancer Center
-
Nashville, Tennessee, Spojené státy, 37204
- Vanderbilt Breast Center at One Hundred Oaks
-
-
Texas
-
Dallas, Texas, Spojené státy, 75235
- Parkland Memorial Hospital
-
Dallas, Texas, Spojené státy, 75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
Houston, Texas, Spojené státy, 77030
- Houston Methodist Hospital
-
Houston, Texas, Spojené státy, 77030
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
-
Houston, Texas, Spojené státy, 77030
- Ben Taub General Hospital
-
-
Utah
-
American Fork, Utah, Spojené státy, 84003
- American Fork Hospital / Huntsman Intermountain Cancer Center
-
Cedar City, Utah, Spojené státy, 84720
- Sandra L Maxwell Cancer Center
-
Farmington, Utah, Spojené státy, 84025
- Farmington Health Center
-
Logan, Utah, Spojené státy, 84321
- Logan Regional Hospital
-
Murray, Utah, Spojené státy, 84107
- Intermountain Medical Center
-
Ogden, Utah, Spojené státy, 84403
- McKay-Dee Hospital Center
-
Provo, Utah, Spojené státy, 84604
- Utah Valley Regional Medical Center
-
Riverton, Utah, Spojené státy, 84065
- Riverton Hospital
-
Salt Lake City, Utah, Spojené státy, 84112
- Huntsman Cancer Institute/University of Utah
-
Salt Lake City, Utah, Spojené státy, 84106
- Utah Cancer Specialists-Salt Lake City
-
Salt Lake City, Utah, Spojené státy, 84143
- LDS Hospital
-
South Jordan, Utah, Spojené státy, 84009
- South Jordan Health Center
-
St. George, Utah, Spojené státy, 84770
- Saint George Regional Medical Center
-
-
Virginia
-
Fredericksburg, Virginia, Spojené státy, 22401
- Fredericksburg Oncology Inc
-
Richmond, Virginia, Spojené státy, 23235
- VCU Massey Cancer Center at Stony Point
-
Richmond, Virginia, Spojené státy, 23298
- VCU Massey Comprehensive Cancer Center
-
-
Washington
-
Aberdeen, Washington, Spojené státy, 98520
- Providence Regional Cancer System-Aberdeen
-
Anacortes, Washington, Spojené státy, 98221
- Cancer Care Center at Island Hospital
-
Auburn, Washington, Spojené státy, 98001
- MultiCare Auburn Medical Center
-
Bellevue, Washington, Spojené státy, 98004
- Overlake Medical Center
-
Bellevue, Washington, Spojené státy, 98005
- Swedish Cancer Institute-Eastside Oncology Hematology
-
Bellingham, Washington, Spojené státy, 98225
- PeaceHealth Saint Joseph Medical Center
-
Centralia, Washington, Spojené státy, 98531
- Providence Regional Cancer System-Centralia
-
Edmonds, Washington, Spojené státy, 98026
- Swedish Cancer Institute-Edmonds
-
Everett, Washington, Spojené státy, 98201
- Providence Regional Cancer Partnership
-
Gig Harbor, Washington, Spojené státy, 98335
- MultiCare Gig Harbor Medical Park
-
Issaquah, Washington, Spojené státy, 98029
- Swedish Cancer Institute-Issaquah
-
Kennewick, Washington, Spojené státy, 99336
- Kadlec Clinic Hematology and Oncology
-
Lacey, Washington, Spojené státy, 98503
- Providence Regional Cancer System-Lacey
-
Longview, Washington, Spojené státy, 98632
- PeaceHealth Saint John Medical Center
-
Port Townsend, Washington, Spojené státy, 98368
- Jefferson Healthcare
-
Puyallup, Washington, Spojené státy, 98372
- MultiCare Good Samaritan Hospital
-
Renton, Washington, Spojené státy, 98055
- Valley Medical Center
-
Seattle, Washington, Spojené státy, 98107
- Swedish Medical Center-Ballard Campus
-
Seattle, Washington, Spojené státy, 98122
- Swedish Medical Center-First Hill
-
Seattle, Washington, Spojené státy, 98112
- Kaiser Permanente Washington
-
Seattle, Washington, Spojené státy, 98104
- Minor and James Medical PLLC
-
Seattle, Washington, Spojené státy, 98104
- Pacific Gynecology Specialists
-
Seattle, Washington, Spojené státy, 98122-5711
- Swedish Medical Center-Cherry Hill
-
Sedro-Woolley, Washington, Spojené státy, 98284
- PeaceHealth United General Medical Center
-
Shelton, Washington, Spojené státy, 98584
- Providence Regional Cancer System-Shelton
-
Spokane, Washington, Spojené státy, 99218
- Evergreen Hematology and Oncology PS
-
Spokane, Washington, Spojené státy, 99204
- MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
-
Spokane, Washington, Spojené státy, 99218
- MultiCare Deaconess Cancer and Blood Specialty Center - North
-
Spokane Valley, Washington, Spojené státy, 99216
- MultiCare Deaconess Cancer and Blood Specialty Center - Valley
-
Tacoma, Washington, Spojené státy, 98405
- Mary Bridge Children's Hospital and Health Center
-
Tacoma, Washington, Spojené státy, 98405
- MultiCare Tacoma General Hospital
-
Vancouver, Washington, Spojené státy, 98664
- PeaceHealth Southwest Medical Center
-
Walla Walla, Washington, Spojené státy, 99362
- Providence Saint Mary Regional Cancer Center
-
Yakima, Washington, Spojené státy, 98902
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
-
Yelm, Washington, Spojené státy, 98597
- Providence Regional Cancer System-Yelm
-
-
Wisconsin
-
Eau Claire, Wisconsin, Spojené státy, 54701
- Marshfield Medical Center-EC Cancer Center
-
Eau Claire, Wisconsin, Spojené státy, 54701
- Marshfield Clinic Cancer Center at Sacred Heart
-
Green Bay, Wisconsin, Spojené státy, 54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay, Wisconsin, Spojené státy, 54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
La Crosse, Wisconsin, Spojené státy, 54601
- Gundersen Lutheran Medical Center
-
Madison, Wisconsin, Spojené státy, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Manitowoc, Wisconsin, Spojené státy, 54221
- Holy Family Memorial Hospital
-
Marinette, Wisconsin, Spojené státy, 54143
- Saint Vincent Hospital Cancer Center at Marinette
-
Marshfield, Wisconsin, Spojené státy, 54449
- Marshfield Medical Center-Marshfield
-
Marshfield, Wisconsin, Spojené státy, 54449
- Marshfield Medical Center
-
Milwaukee, Wisconsin, Spojené státy, 53226
- Medical College of Wisconsin
-
Minocqua, Wisconsin, Spojené státy, 54548
- Marshfield Medical Center - Minocqua
-
Oconto Falls, Wisconsin, Spojené státy, 54154
- Saint Vincent Hospital Cancer Center at Oconto Falls
-
Rice Lake, Wisconsin, Spojené státy, 54868
- Marshfield Medical Center-Rice Lake
-
Sheboygan, Wisconsin, Spojené státy, 53081
- HSHS Saint Nicholas Hospital
-
Stevens Point, Wisconsin, Spojené státy, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Sturgeon Bay, Wisconsin, Spojené státy, 54235-1495
- Saint Vincent Hospital Cancer Center at Sturgeon Bay
-
Wausau, Wisconsin, Spojené státy, 54401
- Marshfield Clinic-Wausau Center
-
Weston, Wisconsin, Spojené státy, 54476
- Marshfield Medical Center - Weston
-
-
Wyoming
-
Casper, Wyoming, Spojené státy, 82609
- Rocky Mountain Oncology
-
Cheyenne, Wyoming, Spojené státy, 82001
- Cheyenne Regional Medical Center-West
-
Cody, Wyoming, Spojené státy, 82414
- Big Horn Basin Cancer Center
-
Cody, Wyoming, Spojené státy, 82414
- Billings Clinic-Cody
-
Sheridan, Wyoming, Spojené státy, 82801
- Welch Cancer Center
-
-
Kritéria účasti
Kritéria způsobilosti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
-
PRE-REGISTRATION
-
Diagnostic bone marrow and/or peripheral blood specimens must be submitted for immunophenotyping and selected molecular testing, and the establishment of BCR/ABL status; testing will be performed by the Eastern Cooperative Oncology Group (ECOG)-American College of Radiation Imaging Network (ACRIN) Leukemia Translational Research Laboratory (LTRL) and reported to the institution
- NOTE: IT IS ESSENTIAL THAT A SAMPLE CONTAINING SUFFICIENT BLAST CELLS BE SUBMITTED TO THE ECOG-ACRIN LTRL AT BASELINE SO THAT SUBSEQUENT BONE MARROW ASSESSMENTS OF MRD CAN BE DONE; IN ADDITION TO ALLOWING THE LTRL TO CONFIRM ELIGIBILITY BASED ON BLAST CELL IMMUNOPHENOTYPE AND BCR/ABL STATUS, IT IS ALSO IMPERATIVE THAT AN ADEQUATE NUMBER OF BLASTS BE BANKED FOR ANALYSIS BY DRS MULLIGHAN/WILLMAN. WITHOUT ADEQUATE BASELINE SAMPLES, PATIENTS WILL NOT BE ABLE TO BE TREATED AND RANDOMIZED ON THIS PROTOCOL; IF A BONE MARROW ASPIRATE IS NOT AVAILABLE FOR LTRL SUBMISSION AT BASELINE, IT IS IMPERATIVE THAT DR PAIETTA FROM THE LTRL IS CALLED TO DISCUSS THE PERIPHERAL BLOOD WHITE BLOOD CELL (WBC) AND BLAST COUNT BEFORE BLOOD ONLY IS SUBMITTED
- NOTE: Hydroxyurea can be given for up to 5 days prior to initiation of protocol therapy for control of leukocyte count and/or other symptoms or signs; corticosteroids can be given after pre-registration to the protocol and submission of baseline marrow and blood samples for control of leukocyte count and/or other symptoms or signs prior to initiation of protocol therapy if needed; if corticosteroids are given prior to pre-registration, contact the study chair as the patient may still be eligible to participate
-
INDUCTION ELIGIBILITY CRITERIA-STEP 1
-
Age >= 30 years and =< 70 years
-
New diagnosis of B lineage ALL must be made upon bone marrow or peripheral blood immunophenotyping; cases with myeloid antigen expression, but unequivocal lymphoid immunophenotype, are eligible
-
Negativity for the Philadelphia chromosome must be established by conventional cytogenetics, fluorescence in situ hybridization (FISH) and/or polymerase chain reaction (PCR); patients who are negative for the Philadelphia chromosome by conventional cytogenetics must have FISH or PCR performed for BCR/ABL to exclude occult translocations
-
Cytogenetic analysis must be performed from diagnostic bone marrow (preferred) or if adequate number of circulating blasts from peripheral blood; FISH testing for common B-lineage ALL abnormalities including t(9;22) (BCR/ABL1), t(12;21) (ETS-variant gene 6 [ETV6]/runt-related transcription factor 1 [RUNX1]), t(1;19) (pre-B-cell leukemia homeobox 1 [PBX1]/transcription factor 3 [TCF3]), +4,+10,+17, (centromeric [Cen]4/Cen10/Cen17), t(11q23;var), (myeloid/lymphoid or mixed lineage leukemia [MLL]), deletion (del)(9p) (cyclin-dependent kinase inhibitor 2A [CDKN2A]/Cen9), and t(14;var) (immunoglobulin heavy chain [IGH] is encouraged); if there are few or no circulating blasts and an adequate marrow sample cannot be obtained for cytogenetic analysis, the patient may still enroll on the trial
-
Serum direct bilirubin < 2 mg/dl or serum total bilirubin =< 3 (obtained =< 48 hours prior to registration); NOTE: the above stipulation for normal hepatic function does not apply if liver dysfunction is due to leukemia infiltration
-
Serum creatinine < 2 mg/dl (obtained =< 48 hours prior to registration); NOTE: the above stipulation for normal hepatic function does not apply if liver dysfunction is due to leukemia infiltration
-
Patient should be human leukocyte antigen (HLA) typed (A, B, C, DR and DQ) during induction therapy phase or a written explanation for not undergoing HLA typing on the flow sheet
-
Patients with known human immunodeficiency virus (HIV) infection are eligible if they meet all of the following criteria:
- No history of acquired immune deficiency syndrome (AIDS)-related complications other than a history of low CD4+ T-cell count (< 200/mm^3) prior to initiation of combination antiretroviral therapy; on study CD4+ T-cell count may not be informative due to leukemia and should not be used as an exclusion criterion if low
- Patient must be healthy on the basis of HIV disease with high likelihood of near normal life span were it not for the leukemia
- Patient must have serum HIV viral load of < 200 copies/mm^3
- Patient must be on combination antiretroviral therapy with minimal pharmacokinetic interactions with study therapy and minimal overlapping clinical toxicity with protocol therapy
- Patient must not be receiving protease inhibitors or once daily formulations containing cobicistat, stavudine, or on regimens containing stavudine or zidovudine
- It is recommended to utilize a regimen of the integrase inhibitor, dolutegravir, combined with either disoproxil fumarate/emtricitabine or dolutegravir combined with tenofovir alafenamide/emtricitabine
-
Patient must have no history of recent myocardial infarction (within three months), uncontrolled congestive heart failure, or uncontrolled cardiac arrhythmia
-
Patient must have a normal cardiac ejection fraction by pretreatment multigated acquisition scan (MUGA) or echocardiogram within 4 weeks prior to registration (resting ejection fraction >= 40% or >= 5% increase with exercise), shortening fraction by echocardiogram >= 24%, or to within the normal range of values for the institution
-
Women must not be pregnant or breast-feeding due to administration of teratogenic chemotherapy and must not become pregnant or breastfeed during protocol therapy and for at least 3 months after protocol therapy; woman of childbearing potential must abstain from sexual activity or be willing to use 2 highly effective forms of contraception throughout protocol therapy and for at least an additional 3 months after the last dose of protocol-specified therapy; all females of childbearing potential must have a blood test or urine study within 2 weeks prior to registration to rule out pregnancy; a female of childbearing potential is any woman, regardless of whether they have undergone tubal ligation, who meets the following criteria: has not undergone a hysterectomy or bilateral oophorectomy; or has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
-
Men who have a female partner of childbearing potential must be willing to use 2 highly effective forms of contraception throughout protocol therapy and for at least an additional 3 months after the last dose of protocol-specified therapy; men who have a pregnant partner must be willing to use a condom during sexual activity throughout protocol therapy and for 3 months after the last dose of protocol-specified therapy
-
ECOG performance score 0-3
-
Patient must have given written informed consent
-
POST-INDUCTION THERAPY ELIGIBILITY CRITERIA (PRIOR TO INTENSIFICATION-STEP 2)
-
ECOG performance status 0-2
-
Patients must have achieved a CR or CRi
-
Patients who have achieved a CR or CRi must have maintained peripheral blood evidence of a CR or CRi
-
Patient must be CNS (cerebrospinal fluid [CSF]) negative for leukemia
-
Patients must have resolved any serious infectious complications related to induction
-
Any significant medical complications related to induction must have resolved
-
Serum creatinine =< 2.0 mg/dl (obtained =< 48 hours prior to registration)
-
Serum direct bilirubin < 2 mg/dL or serum total bilirubin =< 3 (obtained =< 48 hours prior to registration)
-
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) < 3 x upper limit of normal (ULN) (obtained =< 48 hours prior to registration)
-
RANDOMIZATION OR ASSIGNMENT TO BLINATUMOMAB OR NO BLINATUMOMAB-STEP 3
-
Patients must have an ECOG performance status of 0-2
-
Patients must have maintained peripheral blood evidence of a remission and must have a CR or CRi, confirmed on restaging bone marrow (BM) aspirate and biopsy
-
Patients must have resolved any serious infectious complications related to therapy
-
Any significant medical complications related to therapy must have resolved
-
Direct or total bilirubin < 1.5 x ULN (unless related to Gilbert's or Meulengracht's syndrome); the values must be obtained within 48 hours prior to randomization
-
Serum creatinine < 1.5 x ULN; the values must be obtained within 48 hours prior to randomization
-
Bone marrow aspirates must be submitted for centralized minimal residual disease (MRD) assessment performed by the ECOG-ACRIN Leukemia Translational Research Laboratory
-
MRD results will be reported to the submitting institution
-
NOTE: FOR MRD ASSESSMENTS, AN ASPIRATE FROM A SEPARATE BONE MARROW ASPIRATION SITE MUST BE SUBMITTED (THE NEEDLE CAN BE RE-DIRECTED THROUGH THE SAME SKIN PUNCTURE SITE); ONLY SUBMIT ASPIRATES FROM THE FIRST PULL OF AN ASPIRATION SITE FOR MRD TESTING; DO NOT SUBMIT SAMPLES FROM THE SECOND OR THIRD PULL OF THE SAME ASPIRATION SITE
-
In B-lineage ALL, MRD levels in peripheral blood or from a dilute marrow aspiration can be 300% lower, on average, than those in bone marrow at a given time point; submitting a first pull from a separate aspiration site will ensure that MRD determinations used in randomization and trial interpretation are accurate
- NOTE: failure to submit bone marrow aspirates will result in a major violation at the time of an audit
-
-
CRITERIA FOR ALLOGENEIC TRANSPLANTATION
-
A suitable donor must be identified; there are no restrictions on donor type and can include a matched sibling, a matched or mismatched unrelated donor, a family haplotype matched donor or a cord blood donor (single or double)
-
Patients should meet the eligibility criteria for RANDOMIZATION OR ASSIGNMENT TO BLINATUMOMAB OR NO BLINATUMOMAB-STEP 3
-
Patients must be considered reliable enough to comply with the medication regimen and follow-up, and have social support necessary to allow this compliance
-
CRITERIA FOR MAINTENANCE THERAPY-STEP 4: Patients must have an ECOG performance status of 0-3
-
CRITERIA FOR MAINTENANCE THERAPY-STEP 4: Patients must have maintained peripheral blood evidence of a remission and must have a CR or CRi, confirmed on restaging BM aspirate and biopsy
-
CRITERIA FOR MAINTENANCE THERAPY-STEP 4: Patients must have resolved any serious infectious complications related to therapy
-
CRITERIA FOR MAINTENANCE THERAPY-STEP 4: Any significant medical complications related to therapy must have resolved
Exclusion Criteria:
- Mature B ALL (Burkitt's-like leukemia) is excluded from enrollment in this trial; pre-study bone marrow biopsy and aspirate must be completed =< 1 week prior to registration
- Patient must not have a concurrent active malignancy for which they are receiving treatment
- Patient must not have intercurrent organ damage or medical problems that will jeopardize the outcome of therapy (i.e., psychiatric disorder, drug abuse, pregnancy)
- Patient must not have an antecedent hematologic disorder
- Patient must not have a history or presence of clinically relevant central nervous system (CNS) pathology such as epilepsy, seizure, paresis, aphasia, stroke, severe brain injuries, dementia; Parkinson's disease, cerebellar disease, organic brain syndrome, psychosis, or other significant CNS abnormalities
- Patient must not have an active uncontrolled infection
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Počet zbraní
Zbraně a zásahy
Skupina účastníků / ArmSkupina účastníků / Arm |
Intervence / LéčbaIntervence / Léčba |
|---|---|
|
Experimentální: Arm I (blinatumomab, chemotherapy)
See Detailed Description |
Given IV
Ostatní jména:
Given PO
Ostatní jména:
Undergo bone marrow biopsy
Ostatní jména:
Undergo blood sample collection
Ostatní jména:
Given IV
Ostatní jména:
Given IV
Ostatní jména:
Given IV
Ostatní jména:
Given PO
Ostatní jména:
Undergo allogeneic hematopoietic SCT
Ostatní jména:
Given IV
Ostatní jména:
Undergo bone marrow aspiration Given IT, IV, or SC
Ostatní jména:
Given IV
Ostatní jména:
Given IV
Ostatní jména:
Given IV
Ostatní jména:
Given IV or PO
Ostatní jména:
Undergo lumbar puncture
Ostatní jména:
Given PO
Ostatní jména:
Given PO, IT or IV
Ostatní jména:
Given IM or IV
Ostatní jména:
Undergo x-ray imaging
Ostatní jména:
|
|
Aktivní komparátor: Arm II (chemotherapy)
See Detailed Description |
Given IV
Ostatní jména:
Given PO
Ostatní jména:
Undergo bone marrow biopsy
Ostatní jména:
Undergo blood sample collection
Ostatní jména:
Given IV
Ostatní jména:
Given IV
Ostatní jména:
Given IV
Ostatní jména:
Given PO
Ostatní jména:
Undergo allogeneic hematopoietic SCT
Ostatní jména:
Undergo bone marrow aspiration Given IT, IV, or SC
Ostatní jména:
Given IV
Ostatní jména:
Given IV
Ostatní jména:
Given IV
Ostatní jména:
Given IV or PO
Ostatní jména:
Undergo lumbar puncture
Ostatní jména:
Given PO
Ostatní jména:
Given PO, IT or IV
Ostatní jména:
Given IM or IV
Ostatní jména:
Undergo x-ray imaging
Ostatní jména:
|
Co je měření studie?
Primární výstupní opatření
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Overall Survival (OS) Among Patients Who Were MRD Negative After Induction and Intensification Chemotherapy
Časové okno: Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
Overall survival is defined as the time from randomization to death of any cause. |
Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
Sekundární výstupní opatření
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Relapse-free Survival (RFS) Among Patients Who Were MRD Negative After Induction and Intensification Chemotherapy
Časové okno: Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
RFS was defined as time from randomization to relapse or to death without documentation of relapse. Patients without events were censored at the date of last disease assessment. Relapse/Persistent Disease Persistent disease/Relapse following complete remission (CR)/complete remission incomplete (CRi) is defined as:
|
Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
|
RFS Among of Those Who Are MRD+ at Randomization and Then Convert to MRD- After 2 Cycles of Blinatumomab to Those Patients Who Are MRD- at Randomization and Remain MRD- After 2 Cycles of Blinatumomab or Consolidation Chemotherapy
Časové okno: Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
RFS was defined as time from end of 2 cycles of blinatumomab to relapse or to death without documentation of relapse. Patients without events were censored at the date of last disease assessment. Relapse/Persistent Disease Persistent disease/Relapse following complete remission (CR)/complete remission incomplete (CRi) is defined as:
|
Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
|
OS Among of Those Who Are MRD+ at Randomization and Then Convert to MRD- After 2 Cycles of Blinatumomab to Those Patients Who Are MRD- at Randomization and Remain MRD- After 2 Cycles of Blinatumomab or Consolidation Chemotherapy
Časové okno: Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
OS was defined as time from end of 2 cycles of blinatumomab to death of any cause |
Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
|
OS Among MRD Negative Patients Who Proceed to Allogeneic Transplant on Study
Časové okno: Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
OS was defined as time from allogeneic transplant to death of any cause. |
Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
Další výstupní opatření
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
To Determine Differences in MRD Kinetics Among Patients With the BCR/ABL1-like B-lineage ALL, and to Compare the OS (and RFS) of Patients With BCR-ABL-like Phenotype With Those Without BCR-ABLlike Phenotype
Časové okno: Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
To determine differences in MRD kinetics among patients with the BCR/ABL1-like B-lineage ALL, and to compare the OS (and RFS) of patients with BCR-ABL-like phenotype with those without BCR-ABLlike phenotype |
Assessed every 3 months for 2 years, then every 6 months for 3 years, then annually for 5 years
|
|
Incidence of Anti-blinatumomab Antibody Formation
Časové okno: Assessed at baseline, end of 2 cycles of blinatumomab, end of 4 cycles of blinatumomab, and end of blinatumomab treatment
|
To evaluate the incidence of anti-blinatumomab antibody formation |
Assessed at baseline, end of 2 cycles of blinatumomab, end of 4 cycles of blinatumomab, and end of blinatumomab treatment
|
Spolupracovníci a vyšetřovatelé
Sponzor
Sponzor
Vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: Mark R Litzow, ECOG-ACRIN Cancer Research Group
Publikace a užitečné odkazy
Obecné publikace
- Seftel MD. Hyper-CVAD: a regimen for all seasons. Lancet Haematol. 2020 Jul;7(7):e501-e502. doi: 10.1016/S2352-3026(20)30179-4. No abstract available.
- Litzow MR, Sun Z, Mattison RJ, Paietta EM, Roberts KG, Zhang Y, Racevskis J, Lazarus HM, Rowe JM, Arber DA, Wieduwilt MJ, Liedtke M, Bergeron J, Wood BL, Zhao Y, Wu G, Chang TC, Zhang W, Pratz KW, Dinner SN, Frey N, Gore SD, Bhatnagar B, Atallah EL, Uy GL, Jeyakumar D, Lin TL, Willman CL, DeAngelo DJ, Patel SB, Elliott MA, Advani AS, Tzachanis D, Vachhani P, Bhave RR, Sharon E, Little RF, Erba HP, Stone RM, Luger SM, Mullighan CG, Tallman MS. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. N Engl J Med. 2024 Jul 25;391(4):320-333. doi: 10.1056/NEJMoa2312948.
- Zhong X, Roberts KG, Wei H, Sun Z, Montefiori LE, Kumar A, Iacobucci I, Baviskar P, Gao Q, Polonen P, Pruett-Miller SM, Schreiber RM, Chang TC, Zhang W, Lei S, Rampersaud E, Fan Y, Wu G, Mattison RJ, Zhang Y, Racevskis J, Lazarus HM, Rowe JM, Arber DA, Wieduwilt MJ, Abou Mourad Y, Shami PJ, Baer MR, Asch AS, O'Dwyer KM, Hall A, Liedtke M, Bergeron J, Wood BL, Pratz KW, Dinner SN, Frey NV, Gore SD, Bhatnagar B, Atallah EL, Uy GL, Jeyakumar D, Lin TL, Willman CL, Podoltsev NA, DeAngelo DJ, Patel S, Elliott MA, Advani AS, Tzachanis D, Vachhani P, Bhave RR, Sharon E, Little RF, Erba HP, Stone RM, Tallman MS, Yang JJ, Luger SM, Paietta E, Litzow MR, Mullighan CG. Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study. Blood. 2026 Oct 5:blood.2026033793. doi: 10.1182/blood.2026033793. Online ahead of print.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Začátek studia
Primární dokončení (Aktuální)
Primární dokončení
Dokončení studie (Odhadovaný)
Dokončení studie
Termíny zápisu do studia
První předloženo
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhadovaný)
První zveřejněno
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Poslední zveřejněná aktualizace
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
- Novotvary
- Onemocnění imunitního systému
- Infekce
- Virová onemocnění
- Novotvary podle histologického typu
- Hematologická onemocnění
- DNA virové infekce
- Lymfatická onemocnění
- Lymfoproliferativní poruchy
- Imunoproliferativní poruchy
- Lymfom, Non-Hodgkin
- Lymfom, B-buňka
- Lymfom
- Leukémie, lymfoidní
- Leukémie
- Infekce virem Epstein-Barrové
- Herpesviridae infekce
- Nádorové virové infekce
- Hemická a lymfatická onemocnění
- Lymfoblastická leukémie-lymfom prekurzorových buněk
- Burkittův lymfom
- Aminokyseliny, peptidy a proteiny
- Proteiny
- Sloučeniny síry
- Organické chemikálie
- Heterocyklické sloučeniny, 1 kruh
- Heterocyklické sloučeniny
- Heterocyklické sloučeniny, 2-prsten
- Heterocyklické sloučeniny, fúzované kroužek
- Vyšetřovací techniky
- Terapeutika
- Klinické laboratorní techniky
- Diagnostické techniky a postupy
- Diagnóza
- Vpichy
- Chirurgické postupy, operativní
- Cytologické techniky
- Nukleové kyseliny, nukleotidy a nukleosidy
- Cytodiagnosis
- Uhlovodíky
- Uhlovodíky, cyklické
- Uhlohydráty
- Fyzické jevy
- Alkaloidy
- Podophyllotoxin
- Tetrahydronaftalenes
- Naftalenes
- Polycyklické aromatické uhlovodíky
- Uhlovodíky, aromatické
- Polycyklické sloučeniny
- Glukosidy
- Glykosidy
- Transplantace
- Vybavení a potřeby
- Enzymy a koenzymy
- Indoly
- Protilátky, monoklonální
- Protilátky
- Imunoglobuliny
- Imunoproteiny
- Krevní proteiny
- Sérové globuliny
- Globuliny
- Puriny
- Cytidin
- Pyrimidinové nukleosidy
- Pyrimidiny
- Těhotenství
- Těhotenství
- Steroidy
- Sloučeniny roztaveného kruhu
- Steroidy, fluorované
- Deriváty benzenu
- Diagnostické techniky, chirurgické
- Kyseliny sulfonové
- Kyseliny síry
- Fosforamidové hořčice
- Sloučeniny hořčice dusíku
- Hořčičné sloučeniny
- Uhlovodíky, halogenované
- Fosforamidy
- Organofosforové sloučeniny
- Nukleosidy
- Formyltetrahydrofoláty
- Tetrahydrofoláty
- Kyselina listová
- Pteriny
- Pteridiny
- Těhotenství
- Těhotenství
- Vinca alkaloidy
- Alkaloidy tryptaminu sezologaninu
- Indolské alkaloidy
- Indolizidiny
- Indoliziny
- Arabinonukleosidy
- Aminopterin
- Antracykliny
- Nafthacenes
- Aminoglykosidy
- Koenzymy
- Elektromagnetické jevy
- Magnetické jevy
- Protilátky, monoklonální, omyl odvozený
- Transplantace buněk
- Terapie na bázi buněk a tkání
- Biologická terapie
- Diagnostické techniky, neurologické
- Elektromagnetické záření
- Záření
- Záření, ionizující
- Benzenesulfonáty
- Arylsulfonáty
- Kyseliny arylsulfonové
- Sloučeniny sulfhydrylu
- Rituximab
- Dexamethason
- Methotrexát
- Prednison
- Cyklofosfamid
- Cytarabin
- Etoposid
- Leukovorin
- Vinkristine
- Daunorubicin
- Merkaptopurin
- Dobesilát vápenatý
- Biopsie
- Manipulace se vzorkem
- BLINATUMOMAB
- Transplantace kmenových buněk
- Spinální punkci
- Dexamethason 21-fosfát
- Rentgenové paprsky
- CT-P10
- deltacortene
- prednyliden
- N, N-dicyklohexyl-isoborneol-10-sulfonamid
- azathiopurin
- Merphos
- pegaspargase
- Phantomy, zobrazování
- Auricularum
- dexamethason acetát
Další identifikační čísla studie
Další identifikační čísla studie
- NCI-2013-02229
- U10CA180820 (Grant/smlouva NIH USA)
- U24CA196172 (Grant/smlouva NIH USA)
- U10CA021115 (Grant/smlouva NIH USA)
- NCI-2013-02229 (Identifikátor registru: CTRP (Clinical Trial Reporting Program))
- ECOG-E1910
- E1910 (Jiný identifikátor: CTEP)
- PE1910_A08PAMDREVW01
- E1910 (Jiný identifikátor: ECOG-ACRIN Cancer Research Group)
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .